Susquehanna International Group’s LAVA Therapeutics LVTX Stock Holding History

Susquehanna International Group’s Portfolio LVTX Stock Details LVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-36,200	Closed	-$56.5K	–	13076
2025 Q3	$56.5K	Buy	+36,200	New	+$54.1K	﹤0.01%	11825

Susquehanna International Group's LVTX Position: Q4 2024 in Review

Susquehanna International Group sold out of LAVA Therapeutics (LVTX) in Q4 2024, closing a stake of 48,205 shares — an estimated $80K sold.

Susquehanna International Group first reported a position in LVTX in Q3 2024 and held it in 1 quarter. The position peaked at $80K in Q3 2024. 22 funds tracked by Wall St. Rank hold LVTX as of Q4 2024.

Susquehanna International Group reported no remaining LAVA Therapeutics position as of Q4 2024 after selling out during the quarter.
Susquehanna International Group sold 48,205 LAVA Therapeutics shares in Q4 2024, an estimated $80K.
Susquehanna International Group first reported a position in LAVA Therapeutics in Q3 2024 and held it in 1 quarter.
Susquehanna International Group's LAVA Therapeutics position peaked at $80K in Q3 2024.
22 funds tracked by Wall St. Rank held LAVA Therapeutics as of Q4 2024.

Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.